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Abstract
The purpose of this review is to analyze evidence on prevalence of opioid, alcohol and marijuana
use during pregnancy and answer the PICOT question: In pregnant women addicted to or using
marijuana, opioids, and alcohol, how do non-pharmacological interventions, compared to
standard care of pharmacological interventions alone, affect health outcomes in mothers and
neonates from birth to hospital discharge? Diagnosis of substance use disorder among pregnant
women is increasing and with it comes increased risk of complications to mother and neonate
including neonatal abstinence syndrome (NAS), fetal alcohol syndrome (FAS) and other
negative neonatal and maternal outcomes. Evidence was reviewed from the online databases,
PubMed and CINAHL. Twenty studies from 2013-2018 were reviewed. Interventions included
specialized comprehensive care, individual care, motivational interviewing (MI), and brief
intervention. There was limited research about the topic, indicating a need for more research to
find the most effective non-pharmacological interventions for these populations.
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There is a rising substance abuse epidemic in the United States (Krans, Bobby, England,
Gedeko, Change, Maguire, Genday, & English, 2018) that affects vulnerable populations who
may be especially susceptible to health-related complications. This epidemic includes pregnant
mothers abusing opioids, alcohol, or marijuana and their neonates affected by this abuse. Recent
studies have shown that between 1998 and 2011, opioid use among pregnant women has
increased 127% (Krans et al., 2018). A substantial number of women, against recommendations,
continue to drink alcohol during pregnancy (Savory, Couves, & Burns, 2014). The rate of
marijuana use has also significantly increased in the past 15 years (Coleman-Cowger, Oga,
Peters, & Mark, 2018). Due to the increase of substance abuse in pregnancy, both the pregnant
mothers and neonates are affected negatively (Krans et al., 2018).
Opioid related deaths from overdose have quadrupled since 1999 in the U.S., resulting in
about 78 deaths per day (Metz, Brown, Martins, & Palamar, 2017). With the increase in opioid
use in pregnant mothers, more children are being born with Neonatal Abstinence Syndrome
(NAS) (Metz, Brown, Martins, & Palamar, 2017). Neonatal Abstinence Syndrome is a
withdrawal syndrome exhibited by opioid-dependent neonates. This syndrome is characterized
by a wide variety of signs and symptoms including feeding difficulties, tremors/seizures, high
pitched cries, poor body temperature control, and other symptoms similar to that of opioid
withdrawal (Patrick, Dudley, Martin, Harrell, Warren, Hatmann, & Cooper, 2018). Neonatal
Abstinence Syndrome is extremely dangerous and can lead to neonatal deaths. Hospital costs for
opioid addicted mothers and neonates have risen from $32 million in 2009 to $1.5 billion in 2012
(Metz, Brown, Martins, & Palamar, 2017). In reproductive-aged women, around one-third have
a prescription for an opioid analgesic (Bakhireva, Shrestha, Garrison, Leeman, Rayburn, &
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Stephen, 2018). It is evident that this problem is a significant crisis in the U.S. and calls for
further attention, especially from nurses who manage the care of these women and neonates.
Alcohol consumption during pregnancy is important to study because it results in harmful
risks in both mothers and neonates. Consumption of alcohol during pregnancy increases risk for
certain fetal alcohol spectrum disorders (FASD), such as fetal alcohol syndrome (FAS), partial
fetal alcohol syndrome, and alcohol-related neurodevelopmental disorder (May, Chambers,
Kalberg, Zellner, Feldman, Buckley, Kopald, Hasken, Xu, Honerkamp-Smith, Taras, Manning,
Robinson, Adam, Abdul-Rahman, Vaux, Jewett, Elliott, Kable, Akshoomoff, Falk, Arroyo,
Hereld, Riley, Charness, Coles, Warren, Jones, & Hoyme, 2018). Approximately 30.3% of
United States pregnancies are affected by prenatal alcohol exposure (PAE) (May et al., 2018).
FASDs are associated with lifelong neurodevelopmental and behavioral disabilities in children,
yet these disorders have received little attention in the research on prevention or treatment
strategies (May et al., 2018).
Marijuana is one of the most commonly used illicit substances during pregnancy (Mark,
Desai, & Terplan, 2015). Within the last decade, marijuana abuse in pregnancy has increased
35% (Mark, Desai, & Terplan, 2015). Use of marijuana during pregnancy increases risk in
pregnancy and neonatal development. These risks include preterm labor, low birth weight,
stillbirth, and neonatal intensive care unit admissions (Mark, Desai, & Terplan, 2015), as well as
differences in neonatal behaviors (Coleman-Cowger, Oga, Peters, & Mark, 2018). These risks
have been shown to decrease or become nonexistent with effective preventative interventions
and treatments (Mark, Desai, & Terplan, 2015). Because the harms of marijuana use for a
pregnant woman and her fetus have not been fully explored and the possibility of unknown side
effects, The American College of Obstetricians and Gynecologists (ACOG) recommends that
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pregnant women not use marijuana (2019). As marijuana use is legalized across the country
(Mark, Desai, & Terplan, 2015), use in pregnant women may also increase, therefore research
into adverse effects should be investigated.
Hospitals around the United States are seeing an increase in neonatal repercussions
related to maternal substance use and abuse (Patrick et al., 2018). Pharmacological treatments
are often supplied to wean mothers and neonates off addictive substances but these alone are not
enough to treat these complicated addictions. While pharmacological interventions provide
beneficial outcomes in treatment by minimizing withdrawal symptoms and cravings, they cannot
help prevent relapse or provide patient education on maintaining a healthy lifestyle for both
mothers and children (Andrews, Motz, Pepler, Jeong, & Khoury, 2018). Addiction is a
multifaceted disease which requires a multifaceted approach to treatment. Mothers who used
substances also need integrated, multi-faceted interventions to support the cessation of substance
use during and following pregnancy (Andrews et al., 2018). To provide the most comprehensive
care, evidence based non-pharmacological interventions need to be examined, critically
appraised, and applied, in addition to the standard practice of pharmacological treatment
(Andrews et al., 2018).
In this systematic review, evidence about the effects of supplemental nonpharmacological interventions, compared with pharmacological interventions alone, in pregnant
mothers and neonates will be identified, reviewed, and critically appraised with practice
recommendations advanced. The purpose of this review is to investigate evidence regarding the
prevalence of opioid, alcohol, and marijuana use during pregnancy as well as
nonpharmacological interventions to benefit neonate and mother. The following question will be
answered: In pregnant women addicted to or using marijuana, opioids, and alcohol, how do
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supplemental non-pharmacological interventions, compared to standard care of pharmacological
interventions alone, affect health outcomes in mothers and neonates between birth to hospital
discharge? This is relevant to the nursing community due to the increase in diagnoses of
substance abuse disorder (Patrick et al., 2018) in women and the increase in negative outcomes
for neonates due to exposure to both licit and illicit substances (Andrews et al., 2018). Recent
studies from the Center of Disease Control and Prevention (CDC) (“Substance Use During
Pregnancy,” 2019) have shown that from 1999 to 2014 opioid use in pregnancy has quadrupled.
Along with this, it is proved that alcohol use in pregnancy has shown long term effects on
neonates, including a variety of Fetal Alcohol Disorders (FADs) (“Fetal Alcohol Spectrum
Disorders…,” 2018). There is still little research done on marijuana use during pregnancy;
common known effects are low birth weight and problems concentrating as the neonate grows
older (“What You Need to…,” 2018). These facts further support and advocate for the need for
nurses to gain knowledge of this subject and more research to be done.
Methods
The articles used for this systematic review were carefully selected using a strict
inclusion and exclusion criteria. Only articles published from 2012-2018 were considered to
review the most current research. Articles were examined to ensure they were peer-reviewed,
and findings were evidence-based. Journals and articles were selected based on credibility and
relevance to the PICOT question. Preference was given to nursing journals.
The population focus of this systematic review is pregnant women with substance abuse
and affected neonates. While selecting articles, only articles with the primary population being
substance abusing pregnant women and affected neonates were used. Studies were not limited to
research conducted in the United States, as research conducted in other countries has generated
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relevant evidence for practice in the U.S. Articles focusing on pharmacological methods of
treating addicted women were not considered. Since this review is centered on
nonpharmacological approaches, research about various therapies and alternative methods were
selected.
When searching for articles, a variety of databases were used including PubMed and
CINAHL. These databases heavily focus on nursing research. An openness to inconsistencies
and contradictions in findings, extensive research into various topical possibilities and use of
diverse keywords in each database search engine were implemented in selection of articles to
ensure that the review is comprehensive and as unbiased as possible. Keywords included:
“pregnant”, “women”, “addiction”, “treatment”, “therapy”, “substance abuse”, and other specific
substances. When searching for research articles based solely on marijuana intervention, studies
were very difficult to find and should be noted as implication for future research.
In the critical analysis of each article, it was necessary for the content to be clear and
concise for consideration in this systematic review. Studies must have used reliable, adequate
samples or explanation of sample inclusion and exclusion criteria. The articles must meet the
strict criteria of this review as mentioned above, and should discuss limitations, especially those
affecting generalizability and show minimal bias.
The content of each article was critically analyzed, leading to the decision to include
them in this systematic review based on inclusion parameters stated above. However, it was
difficult to find many studies answering the PICOT question. Therefore, almost all relevant
studies about interventions for pregnant women addicted to substances were utilized throughout
this systematic review. As more research is done on this prevalent issue, increased
understanding will be generated about the effectiveness of interventions.
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Review of Literature
Opioid Abuse
Prevalence. Several studies were found regarding opioid use during pregnancy. Two
focused on cohorts to find prevalence of opioid use in pregnant women. In general, researchers
agreed that opioid use during pregnancy is a growing problem that needs to be
addressed. Angellota, Weiss, and Friedman (2016) found that in 2012, roughly 1.2% of pregnant
women in the United States are addicted to opioids. These researchers found a positive
correlation between unintended pregnancies and opioid use. Additionally, Metz, Brown,
Martins, & Palamar (2017) found that since 1999, opioid overdose resulting in death has
quadrupled. Polysubstance abuse is another problem many pregnant women are dealing with.
Metz, Brown, Martins, & Palamar (2017) found that of pregnant women with substance abuse
disorder (n=818), 36.8% (n=281) used opioids exclusively, 28.2% (n=241) were polysubstance
users, and 35.0% (n=296) used non-opioid illegal substances. Limitations in this study include
unaccounted for trends, exclusion of institutionalized women, and the inability to infer causality.
Nørgaard, Nielsson, & Heide-Jørgensen (2015) found that out of 950,172 Danish women, 557
(5.9%) were tested positive for opioid use. Exclusive use of the opioid buprenorphine occurred
in 167 pregnancies, and exclusive use of the opioid methadone occurred in 197
pregnancies. Twenty-eight women reported using heroin only, and 165 used a combination
(Nørgaard, Nielsson, & Heide-Jørgensen, 2015). These two studies clearly show that
polysubstance abuse in pregnancy is a significant problem. The number of people who
developed Opioid use disorder (OUD) has gotten so high that the U.S. Department of Health and
Human Services (HHS) has declared a public health emergency in 2017 (“What is the U.S.
Opioid Epidemic?” 2019).
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Prevalence and outcomes in newborns. The increasing prevalence of pregnant women
with OUD has led to an increase in neonates born with Neonatal Abstinence Syndrome (NAS;
Metz, Brown, Martins, & Palamar, 2017). Because the effects of opioids travel to the neonates
through the placenta, neonates are at risk for NAS and other adverse reactions (Nørgaard,
Nielsson, & Heide-Jørgensen, 2015; Patrick et al., 2015). For example, in a sample of 950,172
pregnant women, the median birth weights for neonates affected by opioid addiction during
pregnancy (n=557) were less than the median birth weight of neonates that were not affected
(n=949,615) (Nørgaard, Nielsson, & Heide-Jørgensen, 2015; Patrick et al., 2015). Nørgaard,
Nielsson, & Heide-Jørgensen (2015) also found genital malformations in 46 of the neonates
affected by addiction to opioids during pregnancy. Preterm delivery was prevalent in opioid
exposed neonates (Nørgaard, Nielsson, & Heide-Jørgensen, 2015), as well as respiratory disease,
jaundice, and problems with feeding (Patrick et al., 2015). Patrick et al. (2015) findings are
limited due to potential errors in medical records, not knowing if mothers were taking their
prescription opioids as prescribed, and the inability to account for any illegal substances that may
have been used during the trial. Nørgaard, Nielsson, & Heide-Jørgensen, (2015) and Patrick et
al. (2015) both found that opioid exposed neonates are more susceptible to complications than
non-opioid exposed neonates, and that NAS negatively impacts neonatal development.
According to the CDC, in the latest data available reported in 2014, a neonate is born with NAS
every 15 minutes (“Pregnancy: Neonatal Abstinence Syndrome,” 2019). This is nearly 100
babies a day; about 32,000 babies a year (“Pregnancy: Neonatal Abstinence Syndrome,” 2019).
Nursing interventions. Researchers have examined the effects of various interventions
to decrease the use of opioids in pregnant women and decrease the negative impact on their
neonates. For example, four studies were found on interventions for mothers and neonates
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affected by opioid use disorder; two studies were about specialized comprehensive care
interventions (Andrews et al., 2018; Krans et al., 2018) and two were about individual
interventions (Howard, Schiff, Penwill, Si, Rai, Wolfgang, Moses, & Wachman, 2017; Lander,
Gurka, Marshalek, Riffon, & Sullivan, 2015). In general, the interventions found to be most
effective in mothers and their neonates involved specialized comprehensive care that included
treatment of addiction (Andrews et al., 2018; Howard et al., 2017; Krans et al., 2018; Lander et
al., 2015), prevention of relapse (Andrews et al., 2018; Krans et al., 2018; Lander et al., 2015),
patient education (Andrews et al., 2018; Howard et al., 2017), and maintaining healthy motherchild relationships (Andrews et al., 2018; Krans et al., 2018; Howard et al., 2017). Pregnant
women who participated in specialized comprehensive interventions were more likely to attend
postpartum visits (67.9% vs 52.6%; intervention group n=71, control group n=177; Krans et al.,
2018), have increased rates of breastfeeding during childbirth hospitalization (14.7% vs. 37.0%;
Krans et al., 2018), receive long-acting reversible contraceptive methods following deliveries of
neonates (23.9% vs. 13.0%; Krans et al., 2018), maintain custody of their children (60.6%;
n=160; Andrews et al., 2018), and end services with goals met if they attended services with
regular frequency (18.8%; Andrews et al., 2018). Howard et al. (2017) found that parental
presence also known as rooming-in was documented at 68% (n=86) and the mean Neonatal
Abstinence Syndrome (NAS) was significantly lower in neonates who were breastfed. A 100%
parental presence was significantly associated with a one point decrease in the mean NAS score
(-0.52 to -0.15), a nine day decrease in the length of stay (-0.48 to -0.10), and eight fewer days of
opioid therapy (-0.52 to -0.15; Howard et al., 2017). Findings from these studies support the
continuous need for new non-pharmacological interventions to be implemented into healthcare.
Alcohol Abuse
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Prevalence. Researchers have examined the prevalence of alcohol abuse in pregnant
women. Two studies were found on the prevalence of alcohol consumption during
pregnancy. Researchers have examined cross-sectional data on prevalence (Savory, Couves, &
Burns, 2014) as well as prospectively on prevalence in both alcohol use disorder in correlation
with other substances (Bakhireva et al., 2018). In general, researchers have found that
prevalence of alcohol abuse in mothers ranged from 8.5% to 30.3% (Bakhireva et al., 2018). In a
cross-sectional survey of pregnant women (n=470), Savory, Couves, and Burns (2014) found
that 74% reported no drinking in the past 3 months, 18% reported monthly drinking or less, and
7.8% reported frequent drinking. This survey sample comprised of pregnant women attending
their first antenatal appointments during an estimated 10-11 weeks gestation (Savory, Couves, &
Burns, 2014). Alcohol consumption is prevalent early in pregnancy as well in the
periconceptional period. In a study of 660 pregnancies, Bakhireva et al. (2018) found that 15%
of pregnant women (n=660) consumed on average at least three drinks per week, consistent with
the national report of 8.5% to 30.3% prevalence for alcohol use during pregnancy (Bakhireva et
al., 2018). Findings from both studies support the need for more interventions and education
provided for patients suffering from these conditions.
Prevalence and outcomes in neonates. Studies have been done to examine the
prevalence of alcohol abuse in pregnancy and the outcomes in neonates; two studies were found
relevant to this systematic review. Researchers have studied prevalence by using an active-case
ascertainment with a cross-sectional design (May et al., 2018) and in a case study regarding one
school of students (Lubbe, Walbeek, & Vellios, 2017). Lubbe, Walbeek, & Vellios (2017) found
an increase prevalence of adverse outcomes in newborns, such as Fetal Alcohol Syndrome. May
et al. (2018) found no increase in prevalence. There are some inconsistent findings reported by
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the two groups of researchers. Lubbe, Walbeek, & Vellios (2017) reported prevalence of fetal
alcohol disorder at 12.7% (127 per 1000 people) in a sample of 166. These findings are
inconsistent with May et al., (2018) who found estimated prevalence as a wide range of 9.7 to
50.4 per 1000 children (n=6639), which is comparable to the national average and a decrease
from the findings from Lubbe, Walbeek, & Vellios (2017). Reasons to why this may be is that
Lubbe, Walbeek, & Vellios (2017) focused mainly on fetal alcohol disorder while May et al.
(2018) focused on the full spectrum of alcohol causing disorders. A major limitation of the case
study (Lubbe, Walbeek, & Vellios, 2017), compared to the cross-sectional study (May et al.,
2018), is that it would be difficult to compare findings to other studies since it only focused on
Fetal Alcohol Disorder specifically. It also had a small sample of 166 students in one area of
South Africa, which could influence the results (Lubbe, Walbeek, & Vellios, 2017). Even
though there is a difference in prevalence in findings in these two studies, it is still essential for
new interventions to be put in place to decrease the long term and harmful effects of alcohol use
during pregnancy.
Nursing interventions. Researchers have examined a diverse set of interventions for
pregnant women who use alcohol during pregnancy, such as motivational interviewing (MI;
Osterman, Carle, Ammerman, & Gates, 2014; Rendall-Mkosi, Morojele, London, Moodley,
Singh, & Girdler-Brown, 2012) and brief interventions of counseling. All aimed to decrease the
risk of alcohol consumption during pregnancy (Kaner, Bland, Cassidy, Coulton, Dale, Deuca,
Gilvarry, Godfrey, Heather, Myles, Newbury-Birch, Oyefeso, Parrott, Perryman, Phillips,
Shepherd, & Drummond, 2013). In general, researchers have found that multiple sessions of MI,
which is a holistic approach to counseling aimed at helping individuals make choices about
behavior, had positive results in decreasing alcohol consumption during pregnancy (Osterman et
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al., 2014; Rendall-Mkosi et al., 2012). The effectiveness of MI increased when used longer than
one-month duration whether during pregnancy or in anticipation of pregnancy (Rendall-Mkosi et
al., 2012). For example, in a sample of 165 women aged 18-44 years, researchers found that a
five session MI intervention was effective for women at risk for giving birth to neonates with
FAS. Regular implementation of MI was also found effective as part of routine pregnancy care
(n=165; Rendall-Mkosi et al., 2012). In contrast, a single session MI intervention was not
effective in decreasing alcohol consumption (N=122; Osterman et al., 2014). Two 15-minute
brief interventions of brief counseling, provided by a physician with follow-up phone calls
(N=3562; Kaner et al., 2013), were found to be an ineffective intervention to decrease alcohol
consumption. In summary, MI, a theory-based intervention, when used to decrease maternal
intake of alcohol before and during pregnancy, has been used effectively when women attend
multiple sessions although the specific reason for success has yet to be investigated (Osterman et
al., 2014).
Marijuana Abuse
Prevalence. Researchers have found recent increases in marijuana use in women of
childbearing age. In general, that marijuana abuse among women of childbearing age increased
by 35%, according to hospital admission records from 1998 to 2003 in the United States (Mark,
Desai, & Terplan, 2015). From 2005-2014, Coleman-Cowger, Oga, Peters, & Mark (2018)
found that 1% of pregnant women in the United States admitted to marijuana use. However, the
actual number of users could be higher, because perhaps pregnant women under-report use
because of social desirability and fear that parenting may be questioned. Mark, Desai, & Terplan
(2015) found that pregnant marijuana users were less likely to graduate from high school and
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more likely to be unemployed than those who had a negative marijuana screen. They were also
more likely to report feelings of depression.
In a study of 396 pregnant women, Mark, Desai, & Terplan (2015) found that 116 of
these women tested positive for marijuana during prenatal care, and only three produced a
positive toxicology screen at the time of delivery. There is a lack of research on the prevalence
of marijuana use in pregnant women, however, those studying this problem have found slight
increases in marijuana use among pregnant women.
Prevalence and outcomes in neonates. Few researchers have examined the effects and
outcomes in newborns who are exposed to marijuana abuse prenatally. Those who have
researched this problem have looked at developmental effects on neonates into childhood using a
retrospective cohort study (n=6,841; Warshak, Regan, Moore, Magner, Kritzer, & Van Hook,
2015) and a secondary analysis of randomized-controlled trial (n=1867; Dotters-Katz, Smid,
Manuck, & Metz, 2017). Researchers have studied the neonatal adverse outcomes of preterm
delivery (Warshak et al., 2015), preeclampsia (Warshak et al., 2015), gestational diabetes
(Warshak et al., 2015), cesarean delivery (Warshak et al., 2015), fetal growth restriction
(Warshak et al., 2015), perinatal mortality (Warshak et al., 2015), childhood and neonatal
morbidity (Dotters-Katz, Smid, Manuck, & Metz, 2017), periventricular leukomalacia (DottersKatz, Smid, Manuck, & Metz, 2017), and bronchopulmonary dysplasia (Dotters-Katz, Smid,
Manuck, & Metz, 2017). In general, researchers found no increased risk of severe negative
obstetrical outcomes in newborns with the use of marijuana use during pregnancy (Warshak et
al., 2015). In a secondary analysis, researchers found that in a sample of 1867, 138 (7.2%) were
exposed to marijuana use during pregnancy (Dotters-Katz, Smid, Manuck, & Metz, 2017); no
differences were noted in neonatal or childhood outcomes in unexposed marijuana pregnancies
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versus pregnancies exposed to marijuana. Future researchers should continue studying
prevalence and effects of marijuana use in pregnant women on these and other longer-term
outcomes.
Nursing interventions. As previously mentioned, despite repeated search efforts, only
one intervention study of pregnant women using marijuana was found. This may be due to
polysubstance abuse rather than solely marijuana abuse in pregnant women. Increase in research
to study the effects of marijuana through intervention studies is anticipated as legalization of
marijuana increases in the United States. Gray, Beatty, Svikis, Puder, Resnicow, Konkel, &
Ondersma (2017) studied the effects of motivational interviewing (MI) techniques through
electronic brief messaging and found that MI was effective in this population. Using a small
sample of ten pregnant women, the researchers found that 9 out of 10 women reported that the
intervention caused them to be more likely to decrease their marijuana use during
pregnancy. Overall, more research is needed involving non-pharmacological interventions for
mothers and neonates affected by marijuana use as it becomes more prevalent in healthcare in
the future.
Critical Appraisal of Evidence
Limitations. Although there is accuracy of this systematic review, it is not without limitations.
A limitation of this review is the lack of articles provided; specifically, information found
regarding the use of marijuana during pregnancy. Twenty journals were reviewed and
compared. There was limited research found on the nonpharmacologic interventions used on
mothers abusing marijuana during pregnancy. Also, information was not limited to studies
inside the United States. Two studies were used from Denmark (Nørgaard, Nielsson, & HeideJørgensen, 2015) and South Africa (Lubbe, Walbeek, & Vellios, 2017) to support this systematic
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review. Journals were searched with CINAHL and PubMed but some valuable journals found
were required to be purchased. This is a limitation in the review. Findings of the review may be
limited due to the fact only published and readily available journals were used. Journals were
searched back to 2012 in order to find at least 20 published writings. This limitation could alter
the information as to be outdated. Since this review group had a total of four (4) researchers, it is
appropriate to speculate that while searching for relevant articles, personal bias or opinions on
certain studies could have been present. It is correct to assume every researcher is different in the
selection of consistent articles.
Reliability & Validity. The most common design method that was found was retrospective
cohort (Warshak et al., 2015; Mark, Desai, & Terplan et al., 2015; Howard et al., 2017; Krans et
al., 2018; Patrick et al., 2018; Nørgaard, Nielsson, & Heide-Jørgensen, 2015). In a retrospective
cohort, researchers investigate past studies or occurrences to determine possible causative
factors. Limitations of this type of design include that they are viewing this information after the
actual event of recording and that the researchers cannot definitively say that the independent
variable caused the dependent variable. Therefore, all conclusions are based in probability and
likelihood.
Randomized control trial (Dotters-Katz, Smid, Manuck, & Metz, 2017; Lander et al.,
2015; Osterman et al., 2014; Rendall-Mkosi et al., 2012; Kaner et al., 2013) is a method design
where participants are assigned to either an interventional group or control group. This type of
design is performed in a controlled setting, targeting a specific nursing intervention, and has a
measurable outcome. Limitations to this type of design include participation bias, being that the
volunteered participants may not be a correct representation of the targeted population as a
whole.
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Another methodology used was cross-sectional design (Savory, Couves, & Burns, 2014;
May et al., 2018; Coleman-Cowger, Oga, Peters, & Mark, 2018; Metz, Brown, Martins, &
Palamar, 2017). Cross-sectional design uses observation to compare the results of different
participants at the same time. Advantages of this design include that researchers can compare
outcomes quickly and that readers get information on prevalence of outcomes and/or exposure.
They are especially helpful in establishing a baseline in cohort studies and in planning cohort
studies. However, no design is perfect, and the cross-sectional design is no exception.
The next design methods that will be discussed were seen less than the prior design
methods. A case study design was observed (Lubbe, Walbeek, & Vellios, 2017). In this type of
design researchers focus on a single patient or community. Detailing diagnosis, nursing care,
and environmental factors. In this type of method, researchers directly observe their subject. A
great limitation to this type of method is the small amount of data it collects specifically on one
patient or community, causing it to be less reliable than others. Another design method used was
prospective cohort (Bakhirva et al., 2018). A prospective cohort study is a longitudinal cohort
study that follows a group of individuals over time, often for years, to determine how different
factors affect rates of outcomes. Relative to the other observational study designs, prospective
cohort studies hold the strongest level of evidence. Advantages of this design include the
extended length of the observation. Researchers are able to collect more evidence regarding
their subject of study and possibly discover data that would not have been found had the study
been for only weeks as compared to years.
Another design method used was quasi-experimental (Andrews et al., 2018). Quasiexperimental studies are similar to experimental design studies with the exception of using a
non-randomized cohort. This means that is weaker than the standard experimental study but is
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more reasonable to complete in a healthcare study. While quasi-experimental studies are
weaker, they provide a good starting point to see the beginning of causality. Another design
method used was logistic regression analysis (Angelotta, Weiss, Angelotta, & Friedman, 2016).
This method is used to estimate a data value based on past observations of a data set. It
examines the link between one or more present independent variables whilst predicting a
dependent variable. A limitation to this specific method is it is unable to predict continuous
outcomes.
The design methods and findings of the studies are reliable due to the fact that most of
the studies analyzed showed similar results. A majority of these studies showed negative
outcomes between using marijuana, opioids, or alcohol during pregnancy as well as provided
more information on neonate and mother outcome while using these illicit substances (Angelotta
et al., 2016; Nørgaard, Nielsson, & Heide-Jørgensen, 2015; Andrews et al., 2018; Kaner et al.,
2013; Rendall-Mkosi et al., 2012; Osterman et al., 2014; Lander et al., 2015; Lubbe, Walbeek,
& Vellios, 2017; Patrick et al., 2018; Krans et al., 2018; Howard et al., 2017; Mark, Desai, &
Terplan et al., 2015; Bakhirva et al., 2018; Warshak et al., 2015; Metz, Brown, Martins, &
Palamar, 2017; May et al., 2018; Savory, Couves, & Burns, 2014). Only one study showed no
negative effect on neonate or mother outcome on use of marijuana during pregnancy (DottersKatz, Smid, Manuck, & Metz, 2017). Overall, all studies evaluated have shown a need for
attention and further research in this area.
Savory and colleagues (2013) surveyed pregnant women to report their amount of drinks
of alcohol per day consumed. The study did not specify what the term “drink” meant. This
meaning, what one participant would consider moderate consumption of alcohol could be what
another participant considers excessive . Therefore, this could skew the results on the exact
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amount of alcohol consumption during pregnancy (Savory et al., 2013). Similar limitations
across studies included social desirability and personal bias. These studies speculated that their
subjects may have lied about marijuana, alcohol, and opioid use during pregnancy due to fear of
being stigmatized and looked down upon by the researchers or peers (Bakhireva et al., 2018;
Mark., Desai, & Terplan, 2015; Metz, Brown, Martins, & Palamar, 2017; and Rendall-Mkosi et
al., 2012). Research bias was a similar limitation found across studies. Some studies only
included non-institutionalized pregnant woman, causing an underrepresentation of the population
(Metz, Brown, Martins, & Palamar, 2017). Small sample sizes lead to lack of generalization of
the data found in the studies and is common in health care studies due to not enough resources or
time for a study with a large number of participants to take place (May et al., 2018; Howard et
al., 2017). Due to the large number of retrospective cohort studies, errors of omission and
commission were also common (Warshak et al., 2015; Mark, Desai, & Terplan et al., 2015;
Howard et al., 2017; Krans et al., 2018; Patrick et al., 2018; Nørgaard, Nielsson, & HeideJørgensen, 2015). Errors of omission means the information that was gathered from the past in
the retrospective cohort may have been left out. In comparison, errors of commission means that
the information available may have been put in incorrectly. This causes a mishap in data
collection as a whole.
Synthesis of Evidence
The results of this systematic review is that eight (8) of the articles involved focused on
opioid abuse during pregnancy, eight (8) of the articles involved focused on alcohol abuse during
pregnancy, and four (4) articles involved focused on marijuana use during pregnancy.
The most effective interventions for mothers and their neonates affected by opioid abuse
included treatment of addiction (Andrews et al., 2018; Howard et al., 2017; Krans et al., 2018;
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Lander et al., 2015), prevention of relapse (Andrews et al., 2018; Krands et al., 2018; Lander et
al., 2015), maintaining healthy mother-child relationships (Andrews et al., 2018; Krans et al.,
2018; Howard et al., 2017), and patient education (Andrews et al., 2018; Howard et al., 2017).
Other individual intervention that was found to be beneficial for neonates was 100% parental
presence at bedside due to the increased frequency of breastfeeding and mother-child bonding
that decreased the mean NAS score (Howard et al. 2017). Regarding alcohol use during
pregnancy, motivational interviewing proved to be a significant intervention (Osterman et al.,
2014; Rendall-Mkosi et al., 2012). Motivational interviewing was also used in the one article
found on non-pharmacological interventions regarding marijuana use during pregnancy (Gray et
al., 2017). This type of non-pharmacological intervention proved to be effective in clinical
practice.
Recommendations
This systematic review looked at 20 different studies generating a wide array of results
regarding drug abuse during pregnancy. After review, the researchers formulated
recommendations for future clinical use. Overall, more research regarding maternal use of illicit
substances during pregnancy needs done and non-pharmacological interventions involving.
Specifically, more research is needed in the area of marijuana use during pregnancy as only three
relevant studies were found. This is important to future research and public health due to the
legalization of marijuana in some U.S. states.
Based on current research done that is supported by this systematic review, Motivational
Interviewing (Osterman, Carle, Ammerman, & Gates, 2014; Rendall-Mkosi, Morojele, London,
Moodley, Singh, & Girdler-Brown, 2012) seemed to be the most effective intervention when
aiding pregnant women addicted to marijuana or alcohol during pregnancy. This intervention
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proved to be the most researched and most effective for these addictions. Since this intervention
proved to be the most research, recommendations for different interventions are encouraged.
As for non-pharmacological interventions involved specialized comprehensive care that
included treatment of addiction (Andrews et al., 2018; Howard et al., 2017; Krans et al., 2018;
Lander et al., 2015), prevention of relapse (Andrews et al., 2018; Krands et al., 2018; Lander et
al., 2015), patient education (Andrews et al., 2018; Howard et al., 2017), and maintaining healthy
mother-child relationships (Andrews et al., 2018; Krans et al., 2018; Howard et al., 2017). This is
best accomplished through coordinated, multidisciplinary care (Andrews et al., 2018). Providing
this type of care is a complex and lengthy process to maximums efficiency in treating mothers
and their neonates. Because of the complexity, the more research done on honing the process of
providing comprehensive care for mother’s with opioid abuse disorder and their neonates, the
better.
Other recommendations for future clinical use is to provide more resources and nonpharmacological interventions for women addicted to marijuana, opioids, and alcohol.
Researchers found it difficult to find relevant intervention studies regarding only nonpharmacological interventions. Pharmacological interventions came in abundance even when
looking for non-pharmacological interventions. Clinical practices should be evaluating nonpharmacological interventions as well to assist women in their addiction.
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Systematic Review Table of Evidence
APA formatted
reference

Andrews, N. C.,
Motz, M., Pepler,
D. J., Jeong, J. J.,
& Khoury, J.
(2018). Engaging
mothers with
substance use
issues and their
children in early
intervention:
Understanding
use of service and
outcomes. Child
Abuse & Neglect,
83, 10-20.
doi:10.1016/j.chia
bu.2018.06.011

Purpose
statement.
Research
question.
Purpose
statement:” to 1)
describe women’s
use of service, 2)
examine how
early
engagement of
pregnant women
related to
postnatal service
use, and 3)
examine the
circumstances in which
women ended
their service
relationship with
Breaking the
Cycle” (p. 1).
Research
question: How
does Breaking the
Cycle help the
gap between the
relationship of
mother and child
that is lacking,
“by providing not

Clinical Practice
Setting, Sampling
methods, Sample
size.
Setting: Toronto,
Canada
Sampling methods:
All mothers were
asked during the
intake process at
BTC.
Sample size: Out
of 168 women who
consented to
participate, 160
were enrolled.

Design. Level
of Evidence.

Findings, Conclusion

Practice & Research
Implications

Limitations of Findings

Design: quasi
experimental

Findings: “...time in service
is generally associated with
better outcomes and
highlights the success of
long-term engagement in
integrated, relationshipsfocused service for mothers
with substance use issues
and their children” (p. 10).

Practice and Research
Implication: “...consider the
implications of a relational
approach to health service
provision, and the additional
resources and supports that
may be necessary to enable
service providers to
implement these essential
services” (p. 10).

Limitations: Available
information varied
across participants, due
to different use of
service and length of
involvement

Level of
evidence: Level
III

Conclusion: “...participating
in service at BTC relates to
increased relationship
capacity and improved
mental health functioning”
(p. 10).
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Angelotta, C.,
Weiss, C. J.,
Angelotta, J. W.,
& Friedman, R.
A. (2016). A
Moral or Medical
Problem? The
Relationship
between Legal
Penalties and
Treatment
Practices for
Opioid Use
Disorders in
Pregnant Women.
Women’s Health
Issues, 26(6),
595-601.
doi:10.1016/j.whi.
2016.09.002

only instrumental
and substance use
support for
mothers with
substance use
issues, but also
focus on
strengthening and
promoting the
mother child
relationship?” (p.
2).
Purpose
statement:
To describe the
“...relationship
between use of
medicationassisted treatment
(MAT) in
pregnant women
with opioid use
disorders, the
standard of care,
and state laws that
permit child abuse
charges for illicit
drug use during
pregnancy” (p.1).

Setting: USA 2012
Sampling method:
“Using publicly
available data on
substance abuse
treatment in the
United States, we
describe patterns in
the use of MAT for
pregnant women
with opioid use
disorders in states
with prenatal child
abuse laws
compared with
states without such
laws” (p.1)
Sample Size:
“In 2012, there
were 8,292
treatment episodes
of pregnant women
with a primary
opioid use disorder
in the United

Design: Metaanalysis
Level of
Evidence:
Level VI

27

Findings:
“In 2012, there were 8,292
treatment episodes of
pregnant women with a
primary opioid use disorder
in the United States for
which data on MAT use
were available. Among
states with laws that permit
child abuse charges for
illicit drug use in pregnancy
(18 states), MAT was used
in 33.15% of treatment
admissions compared with
51.33% of admissions in
states without a law” (p.1).

practice & Research
Implications: “Limitations of
the study include the low
number of participants who
actually completed the study
(only half of those
consented), therefore limiting
our ability to determine
statistical significance among
our primary dependent
variables of retention and
relapse rates. In addition, the
explicit content of the
OBGYN-affiliated providers’
group discussion was not
structured, nor were
satisfaction ratings
administered specific to these
group sessions. Perhaps if
this portion of the
intervention were more
prescribed it would have
added to the efficacy of the
intervention, and the impact
could have been more

Limitations of Findings:
Women may be reluctant
to admit to opioid use
because of the legal
implications.
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Bakhireva, L.N.,
Shrestha, S.,
Garrison, L.,
Leeman, L.,
Rayburn, W.F., &
Stephen, J.M.
(2018).
Prevalence of
alcohol use in
pregnant women
with substance
use disorder.
Drug and Alcohol
Dependence.

Purpose
Statement:
“This study
evaluated selfreported
prevalence of
alcohol use in
patients
participating in a
comprehensive
prenatal care
program for
women with
substance use
disorder” (p. 1).
Research
Question: Is there
a prevalence of
alcohol use in
pregnant women
with substance
use disorder?

States for which
data on MAT use
were available in
TEDS-A. The
majority of the
treatment episodes
were of women
who were age 18 to
29 (71.93%; n ¼
5,965), White
(85.01%; n ¼
7,049), and not
married (72.26%; n
¼ 5,992)” (p. 4)
Setting: Prenatal
care program for
women with
substance use
disorder, and
pregnant women at
general clinics at
the University of
New Mexico
before conception
periods and
between the last
menstrual period
and pregnancy
recognition.
Sampling method:
Conducted in six
prenatal care
clinics associated
with the UNM
departments of
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explicitly measured and
replicated” (p .6).

Design:
evaluated selfreported of
alcohol usage.
This study
evaluated selfreported
prevalence of
alcohol use in
patients
participating in
a
comprehensive
prenatal care
program for
women with
substance use
disorder (SUD;
n = 295), of
which 95% are
treated for
OUD, and
pregnant

Findings: Alcohol
consumption was higher in
patients screened at the
specialty clinic for pregnant
women with SUD. 15% of
pregnant women in general
obstetrics and SUD patients
consume at least 3
drinks/week on average.
Conclusions: This study
demonstrates a high
prevalence of prenatal
alcohol use in early
pregnancy in both groups,
while patients with
SUD/OUD consume more
alcohol. These findings
underscore the need for
targeted screening and
intervention for alcohol use
in all pregnant women,

Findings & Research
implications: To minimize
participation bias, all
pregnant women attending a
scheduled prenatal visit on
days when a study
coordinator was present at
the clinic were offered
screening for the study. First
study using a large U.S.
sample of pregnant women to
characterize periconceptional
and early pregnancy alcohol
use behaviors among women
in a comprehensive treatment
program for SUD (Mostly
SUD)

Limitation of Findings:
Prevalence might be an
underestimation;
information was
obtained from the
screening stage of the
ENRICH study. They
can’t report changes in
alcohol usage later in
pregnancy. , cannot
report the exact number
of subjects with OUD
among MILARGO
points who participated
in the screening since
questions about illicit
drug use were not asked
at the screening stage
due to sensitivity, the
general obstetric group
was recruited mostly
from low risk clinics. .
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OB/GYN or
Family Medicine.
Sampling Size:
Large number of
Hispanic/Latino
participants. 97
(26.6%) from
general obstetrics
group and 74
(25.1%) patients
with SUD were
classified as
binge/chronic
moderate alcohol
users.

women being
served through
general
obstetrical
clinics at the
University of
New Mexico (n
= 365). During
the screening
phase of a
prospective
study, patients
were asked to
report alcohol
use in the
periconceptiona
l period, and
between the last
menstrual
period and
pregnancy
recognition.
Results: The
screening
interview was
conducted at
22.3 (median =
22; Q1 = 16;
Q3 = 29)
gestational
weeks. Among
patients
screened at the
SUD clinic,
28.8% and
24.1% reported
at least one

29
especially those with
SUD/OUD
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binge drinking
episode in the
periconceptiona
l period and in
early
pregnancy,
respectively.
The prevalence
of binge
drinking was
similar in the
general
obstetrics
population
(24.7% and
24.4%,
respectively).
Among those
who reported
drinking in
early
pregnancy,
median number
of binge
drinking
episodes was
higher among
patients
screened at the
SUD clinic
(median = 3;
Q1 = 1; Q3 =
10) compared
to the general
obstetrics group
(median = 1;
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Q1 = 1; Q3 = 3;
p < 0.001)

Coleman-Cowger,
V. H., Oga, E. A.,
Peters, E. N., &
Mark, K. (2018).
birth outcomes of
co-use of
Cannabis and
tobacco cigarettes
during pregnancy.
Neurotoxicology
and Teratology,
68, 84-90.
doi:10.1016/j.ntt.
2018.06.001

Purpose
Statement: “The
purpose of this
study is to: 1)
describe the
prevalence of couse of Cannabis
and tobacco
cigarettes
reported by a
convenience
sample of
pregnant women
presenting to two
urban prenatal
clinics; 2) outline
correlates of couse of Cannabis
and tobacco
cigarettes; and 3)
compare birth
outcomes
between pregnant
women who couse Cannabis and
tobacco
cigarettes, who
currently smoke
tobacco cigarettes
but do not use
Cannabis, who
currently use

Setting: Two
University
obstetric clinics in
Maryland from
January to
December 2017.
Sampling Method:
“Pregnant women
were enrolled in
the study if they
met the following
criteria: 1)
currently pregnant;
2) age 18 years or
older; 3) able to
speak and
understand English
suﬃciently to
provide informed
consent; and 4)
natural hair length
at least 3cm to
allow for drug
testing” (p. 2).
Sample Size: 1170
pregnant women
were questioned in
regard to this study
at both clinics, 719
were eligible, and
500 were included.

Level of
Evidence: IV
Design: Quasiexperimental
Level of
Evidence:
Level III

Findings: “The prevalence
rate of Cannabis and
tobacco cigarette co-use as
well as the prevalence rate
of Cannabis only use is
higher than the prevalence
of tobacco cigarette only
use, which is notable given
the focus on tobacco
cessation in clinical
practice” (p. 5). Second, an
association was found
between co-use and smaller
head circumference, but
there was no correlation
between Cannabis use and
low birth weight.
Conclusion: “The
examination of Cannabis
and tobacco co-use during
pregnancy among
marginalized, vulnerable
populations with relatively
high use prevalence is a
highly signiﬁcant endeavor,
particularly as Cannabis
use, its potency, and
availability in the US have
increased in recent years.
Additional research is
needed to better understand

Practice & Research
Implications: Recommended
that a screening tool be
created for pregnant women
who use Cannabis, a greater
focus on health implications
is needed.

Limitations of Findings:
No randomized group
assignment (subjects
were already pregnant
and not for the sake of
the study); more
correlation and not prove
causation
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Cannabis but do
not smoke
tobacco
cigarettes, and
who do not
currently use
Cannabis or
tobacco
cigarettes” (p. 2).

32
how factors such as
potency, reasons for use,
modes of use, trimester of
exposure, and
contextual/environmental
cues may moderate the
relationship between co-use
and health outcomes for
both mother and child” (p.
6).

Research
question: How do
tobacco and
Cannabis interact
synergistically to
influence birth
outcomes?
Dotters-Katz,
S.K., Smid, M.C.,
Manuck, T.A., &
Metz, T.D.
(2017). Risk of
neonatal and
childhood
morbidity among
preterm infants
exposed to
marijuana.
Journal of
Maternal Fetal
Neonatal
Medicine. 30(24).

Purpose
Statement:
“We hypothesized
that MJ-exposed
preterm infants
would have worse
neonatal and
childhood
developmental
outcomes
compared to MJunexposed
infants.” (p. 1.)
Research
Question: What is
the risk of
neonatal and
childhood

Setting: 20
institutions around
the United States
from 1997-2004
Sampling Method:
Criteria:
gestational age at
35 weeks was
selected. Excluded
twin gestations,
infants with major
congenital
anomalies, and
those infants who
delivered after 34
weeks and 6 days
of gestation.
.

Design:
Secondary
analysis of a
multicenter
randomized
controlled trial
Level of
Evidence: I

Findings: 135 (7.2%) were
marijuana exposed. No
differences in neonatal or
childhood outcomes in
marijuana exposed infants
compared to marijuana
unexposed infants.
Conclusion: Among infants
born less weeks of gestation
marijuana exposure was not
associated with adverse
neonatal or childhood
outcomes. Long term follow
up studies are needed to
assess later childhood
neurodevelopmental
outcomes following
marijuana exposure.

Practice and Research
Implications: Data was from
a large prospective
randomized controlled trial.
Childhood
neurodevelopmental
outcomes were collected by
trained pediatricians or
pediatric neurologists. Data
from this study was collected
at 20 centers across the
United States and represent
an ethnic makeup similar to
the general population;
makes the findings more
generalizable.

Limitations:
Inability to assess the
frequency or timing of
marijuana use during
pregnancy. No human
data regarding the fetal
effects of marijuana
based on trimester of
exposure. They did not
have urine drug screen
results on all women;
use may be
underreported. Majority
of babies in these studies
were delivered following
PPROM, an obstetric
complication
traditionally associated
with high rates of
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Gray, J., Beatty, J.
R., Svikis, D. S.,
Puder, K. S.,
Resnicow, K.,
Konkel, J., …
Ondersma, S. J.
(2017). Electronic
Brief Intervention
and Text
Messaging for
Marijuana Use
During
Pregnancy: Initial
Acceptability of
Patients and
Providers. JMIR
Mhealth And
Uhealth, 5(11),
e172.
https://doi.org/10.
2196/mhealth.792
7

morbidity among
preterm infants
exposed to
marijuana?

Sample Size:
n=1867 infants

Purpose
Statement:
“The objective of
the study was to
evaluate, among
pregnant women
and prenatal care
providers, the
acceptability of an
electronic brief
intervention and
text messaging
plan for marijuana
use in pregnancy”
(p.1).

Setting: a prenatal
clinic in Detroit,
Michigan

Research
question:
“How acceptable
is electronic brief
intervention and
text messaging
plan for marijuana
use in pregnancy
to pregnant
women and
prenatal care
providers?

Sampling Method:
Patient participants
women recruited
from a prenatal
clinic in Detroit,
Michigan.
Inclusion criteria
were self-report of
marijuana use at
least twice weekly
in the month
before pregnancy,
aged between 18
and 40 years, less
than 20 weeks
pregnant, and
owning a cellphone
(As participants
would be
responsible for any
charges resulting
from receiving text
messages on their
personal phone, all
participants were
specifically asked
their willingness to
receive text

Design:
“Participants
included
patients (n=10)
and medical
staff (n=12)
from an urban
prenatal clinic.
Patientparticipants
were recruited
directly during
a prenatal care
visit. Those
who were
eligible
reviewed the
interventions
individually
and provided
quantitative and
qualitative
feedback
regarding
software
acceptability
and helpfulness
during a oneon-one
interview with
research staff.
Provider-
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“Patient-participants
provided high ratings for
satisfaction, with mean
ratings for respectfulness,
interest, ease of use, and
helpfulness ranging between
4.4 and 4.7 on a 5-point
Likert scale. Of the 10
participants, 5 reported that
they preferred working with
the program versus their
doctor, and 9 of 10 said the
intervention made them
more likely to reduce their
marijuana use. Providerparticipants received the
program favorably, stating
the information presented
was both relevant and
important for their patient
population.”

“These findings suggest that
the women in this study were
open to examining their
marijuana use during
pregnancy and to doing so
via technology. Participants
were happy with the
unbiased presentation of the
effects of marijuana on the
baby, found the materials
useful and easy to use, and
clearly spent time evaluating
whether or not they should
stop use during pregnancy.”

neonatal and childhood
morbidity and mortality
due to an increased
likelihood of infectious
morbidity.
This study is limited by
its relatively small
sample size of all
African American
women from a clinic in
the urban Detroit area.
However, Their aim was
not to conduct a fully
powered test of an a
priori hypothesis, but
rather to provide
information regarding
participant acceptability
and usability, which
typically involves
smaller sample sizes.
Additionally, it may
have been preferable to
present text messages for
feedback as a
presentation where each
text message could be
looked at separately.
Having a single
document with a sample
of each week's messages
was overwhelming for
some participants.
Future studies should
also consider ways to
tailor the text messages
for the participants
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messages during a
feedback
interview.).
Exclusion criteria
included inability
to understand
English, inability
to provide consent,
consideration of an
elective abortion or
adoption for the
current pregnancy,
or past
participation in any
other study by the
authors.
ProviderParticipants of the
medical staff from
the same prenatal
clinic, members
volunteered to
participate in focus
groups regarding
the intervention
materials. We
offered
participation to all
physicians in the
department;
physicians were
available to attend
one focus group,
and medical staff
(all of the nurses,
medical assistants,
and reception staff

participants
took part in
focus groups in
which the
intervention
materials were
reviewed and
discussed.
Qualitative and
focus group
feedback was
transcribed,
coded
manually, and
classified by
category and
theme.”

34
providing feedback. This
study was only able to
show examples and
describe how messages
would be tailored and
may have missed
valuable feedback
because of the
presentation format.”
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from the clinic
where recruitment
took place)
participated in the
second focus
group.

Howard, M. B.,
Schiff, D. M.,
Penwill, N., Si,
W., Rai, A.,
Wolfgang, T.,
Wachman, E. M.
(2017). Impact of
Parental Presence
at Infants’
Bedside on
Neonatal
Abstinence
Syndrome.
Hospital
Pediatrics.
doi:10.1542/hped
s.2016-0147

Purpose
statement: “to
examine the effect
of the amount of
parental presence
at the bedside on
NAS severity;
speciﬁcally, the
association with 3
main outcomes:
(1) hospital LOS,
(2) extent of
pharmacologic
therapy required,
and (3) mean
Finnegan
withdrawal
scores” (p. 2).
Research
question:
“examine the
association
between rates of
parental presence
and NAS
outcomes” (p. 2).

Setting: Infants
born at Boston
Medical Center
between March
2015-April 2016
with opioid
exposure prior to
birth.
Sampling methods:
Subjects were
considered eligible
to participate in the
study if: “maternal
opioid agonist
treatment with
methadone or
buprenorphine
during the third
trimester of
pregnancy and
infants with a
gestational age >36
weeks treated with
opioid replacement
therapy for opioid
withdrawal on a
pediatric inpatient
unit” (p. 2).

Design: quasi
experimental;
“retrospective,
single-center
cohort study of
infants treated
pharmacologica
lly for NAS
using a
rooming-in
model of care”
(p. 1).

Findings: Breastfeeding was
associated with decreased
LOS. However, infants who
were breastfed had a higher
percentage of parental
presence. “Across the
cohort, the mean NAS score
when a parent was present
was significantly lower
compared with when a
parent was not present” (p.
4).

Level of
Evidence:
Level III

Conclusion: Study supports
the role of rooming-in and
parental engagement in
infant care for decreasing
withdrawal severity, LOS,
and pharmacological
treatment of infants with
NAS” (p. 6). Breastfeeding
should be encouraged in
order to decrease LOS and
increase parental
involvement.

Practice and Research
Implications: Focus on
parental presence to promote
breastfeeding, skin-to-skin
time, and parental-infant
bonding. Additional research
is needed to explore support
programs to help eliminate
the barriers to parental
presence; specifically, “…the
stigma and guilt experienced
by women with substance
use disorders watching their
infants go through
withdrawal” (p. 5).

Limitations: small
sample size, how they
measured parental
presence (new metric for
nurses to chart)
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Kaner, E., Bland,
M., Cassidy, P.,
Coulton, S., Dale,
V., Deuca, P.,
Gilvarry, E.,
Godfrey, C.,
Heather, N.,
Myles, J.,
Newbury-Birch,
D., Oyefeso, A.,
Parrott, S.,
Perryman, K.,
Phillips, T.,
Shepherd, J. &
Drummond, C.
(2013)
Effectiveness of
screening and
brief alcohol
intervention in
primary care
(SIPS trial):
pragmatic cluster
randomized
controlled trial.
BMJ 346, 8501.
doi:
https://doi.org/10.
1136/bmj.e8501

Purpose
Statement &
Research
Question
Research
Question: What is
the effectiveness
of screening and
brief alcohol
intervention in
pregnant women?
Purpose
Statement: To
evaluate the
effectiveness of
different brief
intervention
strategies at
reducing
hazardous or
harmful drinking
in primary care.

Sample size: Out
of 138 infants with
in-utero exposure,
only 86 were
selected to be
included in the
study cohort.
Setting: Primary
care practices in
the north east and
southeast of
England and in
London
Sampling
Methods: 3562
patients aged 18 or
more routinely
presenting in
primary care of
whom 2991 (84%)
were eligible to
enter the trial: 900
(30.1%) screened
positive for
hazardous or
harmful drinking
and 756 (84%)
received a brief
intervention. The
sample was
predominantly
male (62%) and
white (92%) and
34% were current
smokers.
Sample Size: 3562

Design:
Practices were
randomized to
three
interventions,
each of which
built on the
previous one: a
patient
information
leaflet control
group, five
minutes of
structured brief
advice, and 20
minutes of brief
lifestyle
counselling.
Delivery of the
patient leaflet
and brief advice
occurred
directly after
screening and
brief lifestyle
counselling in a
subsequent
consultation.
Pragmatic
cluster
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Findings: Patient follow-up
rates were 83% at six
months (n=644) and 79% at
12 months (n=617). At both
time points an intention to
treat analysis found no
significant differences in
AUDIT negative status
between the three
interventions. Compared
with the patient information
leaflet group, the odds ratio
of having a negative
AUDIT result for brief
advice was 0.85 (95%
confidence interval 0.52 to
1.39) and for brief lifestyle
counselling was 0.78 (0.48
to 1.25). A per protocol
analysis confirmed these
findings
Conclusions: All patients
received simple feedback on
their screening outcome.
Beyond this input, however,
evidence that brief advice or
brief lifestyle counselling
provided important
additional benefit in
reducing hazardous or

Practice and Research
Implications: This research
provided good information
for future research. It would
be beneficial to look into the
specific aspects of brief
intervention to see which part
makes an impact. Research
into how women receive
brief interventions would
allow insight into why it is
effective.

Limitation of Findings:
Inability to initiate more
intense brief
intervention. Lack of
previous research to
build off.
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patients

Krans, E.E.,
Bobby, S.,
England, M.,
Gedekoh, R.H.,
Chang, J.C.,
Maguire,
B.,...English,
D.H. (2018). The
pregnancy
recovery center:
A womencentered
treatment
program from
pregnant and
postpartum
women with
opioid use
disorder.
Addictive
Behaviors

Purpose
statement: “is to
a) evaluate the
impact of womencentered services
on
outcomes among
pregnant and
postpartum
women with OUD
and b)
provide a
programmatic
description of
women-centered
services that
can be used to
inform the clinical
protocols of
treatment
programs that
care for women
with OUD” (p. 2).
Research
question: Does a
women-centered
treatment
program for
pregnant and
postpartum
women with

Setting: MageeWomen’s Hospital
between July 2014
and 2016
Sampling methods:
Among 643
women who gave
birth at this
hospital, 248 were
using
buprenorphine. 71
enrolled in PRC
and 177 were
enrolled in a nonPRC
buprenorphine
treatment program
Sample size: 248
pregnant women
with OUD

randomized
controlled trial
Level of
Evidence:
Level III
Design:
comparison of
two
retrospective
cohorts
Level of
Evidence:
Level IV

37
harmful drinking compared
with the patient information
leaflet was lacking.

Findings: Pregnancy
Recovery Center patients
“had significant
improvement in pregnancyspecific MAT dosing,
postpartum visit attendance,
breastfeeding continuation
rates and postpartum LARC
use” (p. 5).
Conclusion: “Incorporating
women-centered services
into OUD treatment
programming may improve
gender-specific outcomes
among women with OUD”
(p. 1).

Practice and Research
Implications: Further
research is needed to address
the unique needs of pregnant
and postpartum women to
improve the health of women
with OUD and their children

Limitations: difficult to
make claims of cause
and effect, were selfselected into each group;
patients were
predominantly
Caucasian
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Lander, L. R.,
Gurka, K. K.,
Marshalek, P. J.,
Riffon, M., &
Sullivan, C. R.
(2015). A
Comparison of
Pregnancy-Only
versus MixedGender Group
Therapy among
Pregnant Women
with Opioid Use
Disorder. Social
Work Research,
39(4), 235-244.
doi:10.1093/swr/s
vv029

opioid use
disorder improve
outcomes for
mother and child?
Purpose
statement:
“This study aimed
to determine
whether treating
pregnant women
in pregnancy-only
therapy groups
improved
outcomes
compared with
treatment in
mixed-gender
therapy groups”
(p. 1)
Research
question:
Do pregnant
women in
pregnancy-only
therapy groups
show more
improvement than
pregnant women
in mixed-gender
therapy groups?

Setting:
Comprehensive
Opioid Addiction
Therapy (COAT)
outpatient clinic in
West Virginia
Sampling Method:
“inclusion criteria
included
pregnancy with
opioid use
disorders and
seeking
medicationassisted treatment
with
buprenorphine. To
meet eligibility,
participants were
required to obtain
prenatal care and
sign a release of
information for
study staff to
abstract pregnancy
and birth-related
data from their
medical record.
Participants also
were required to
sign the COAT
clinic treatment

Design:
Randomized
control trial
Level of
evidence:
Level II
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Findings:
“The difference in these
retention rates between the
two groups was not
significant” (p.5)
Conclusion:
“Our initial hypothesis was
that a pregnancy-only group
would be superior to TAU
in terms of retention in
treatment, lower rates of
relapse, patient satisfaction,
and quality-of-life
measurements. Our findings
suggest that the two groups
were very similar on all
measures. From this study,
it appears that one of the
most important factors in
managing pregnant patients
with opioid use disorders is
to reduce barriers to
treatment and treat opioid
dependence itself.” (p.8)

Practice and Research
Implications: “Limitations of
the study include the low
number of participants who
actually completed the study
(only half of those
consented), therefore limiting
our ability to determine
statistical significance among
our primary dependent
variables of retention and
relapse rates. In addition, the
explicit content of the
OBGYN-affiliated providers’
group discussion was not
structured, nor were
satisfaction ratings
administered specific to these
group sessions. Perhaps if
this portion of the
intervention were more
prescribed it would have
added to the efficacy of the
intervention, and the impact
could have been more
explicitly measured and
replicated.”(p.8)

Limitations: Small sample
size of only 45.
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Lowe, J., Qeadan,
F., Leeman, L.,
Shrestha, S.,
Stephen, J. M., &
Bakhireva, L. N.
(2017). The effect
of prenatal
substance use and
maternal
contingent
responsiveness on
infant affect.
Early Human
Development,
115, 51–59.
https://doi.org/10.
1016/j.earlhumde
v.2017.09.013

.Purpose
Statement: The
specific aims of
this prospective
cohort study were
to examine: 1) the
differences in
maternal behavior
styles during the
SFP between
women who used
alcohol, opioids,
both substances in
combination, or
abstained from
alcohol and illicit
drugs during
pregnancy; 2) the
contributing
effects of prenatal
substance use and
parenting style
(operationalized
as maternal
contingent
responding) on
infant positive
affect during
maternal-infant
play episodes of
the SFP. We
hypothesized that

agreement
guidelines” (p.3)
Sample size:
45 pregnant
women
Setting: two
consecutive
prospective cohort
studies conducted
at the University of
New Mexico
(UNM) with the
same study
population
Sample methods:
“A prospective
cohort design was
utilized with
repeated
assessment of
substance use
during pregnancy
and the
administration of
the SFP, which
measures infant
response to a social
stressor, at
approximately 6
months of age.
Subjects included
91 dyads classified
into four groups: 1)
Control (n = 34);
2) Medication
assisted therapy for
opioid dependence

Design: Data
were derived
from two
consecutive
prospective
cohort studies
conducted at
the University
of New Mexico
(UNM) with the
same study
population. The
UNM Human
Research
Review
Committee
approved both
studies and
patients gave
written
informed
consent. The
Biomarkers,
Infant
Neurodevelopm
ent, and Growth
(BINGO) study
was conducted
at UNM in
2011–2012 and
served as a pilot
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Findings: “The results of
this study support and
expand our previous
findings in a different
population [47], that a
supportive parenting style,
which includes
acknowledgement of infant
affect (such as when they
were happy or sad) and uses
playful games to re-engage
the infant (such as peek-aboo) explained more
variability in infant
emotional regulation than
prenatal exposure to alcohol
and/or opioids. With respect
to exposure to substances of
abuse, there were no
significant effects of
prenatal substance exposure
on infant affect, although
there was a trend (p =
0.053) for a lower infant
affect in the Alcohol group
compared to Controls in the
last reunion/play episode,
when the child is more
likely to accumulate “carryover effect” from prior SFP
episodes. The lack of
influence of prenatal

Practice and Research
Implications: “Future
directions may include
developing strategies for
teaching parents who have
infants prenatally exposed to
alcohol and other substances
how to respond in a sensitive
manner that is responsive to
their infant's emotion.
Parents can be taught that
certain behaviors, such as
attention seeking, can be less
pleasing or possibly
annoying to their infant,
while simple games, such as
‘peek-a-boo,’ can be fun and
engaging. This could
potentially help improve
infants' positivity, which is
relevant as children
prenatally exposed to alcohol
have been found to have
problems with ‘negative
affectivity’ and irritability .
Future work should also
explore mediation analysis in
the context of the SFP,
focusing on the complexity
of controlling for postnatal
environment and maternal
interaction as mediators.

Limitations of Findings:
“The SFP has been used
extensively in the
literature, but is only a
proxy for a stressful
situation; one can only
infer that the measure of
affect indicates the
infant was upset and
therefore stressed. Early
in life there are many
situations that cause an
infant to become upset,
and the ability to selfcalm or be soothed by a
parent can be indicative
of the infant's ability to
regulate their emotions.
We acknowledge that
the limited effect of
prenatal exposure on
infant affect could be
due to the following
reasons: 1) small sample
size in the Alcohol
group, which potentially
resulted in the results
being of borderline
statistical significance;
2) light-to-moderate
levels of alcohol
consumption in this

INTERVENTIONS FOR DRUG USE IN PREGNANCY
substance using
women will be
less likely to
engage in
contingent
responding
behavior style,
and that maternal
contingent
responding would
be an equally
important
predictor of infant
affect as prenatal
exposure to
substances of
abuse.” (p. 2)
Research
Question: How
does the maternal
contingent
responding of
substance using
women effect
infant affect as
prenatal exposure
to substances of
abuse?

(MAT; n = 19); 3)
Alcohol (n = 15);
4) Alcohol + MAT
(n = 23). Mean %
of positive infant
affect and mean %
of maternal
responsiveness
(watching,
attention seeking,
and contingent
responding) was
compared among
the five SFP
episodes across the
four study groups
by MANOVA.
Mixed effects
modelling was
used to estimate
the contributing
effect” (p. 1).
Sample size: 91
maternal-infant
pair

study to the
larger, ongoing
Ethanol,
Neurodevelopm
ent, Infant and
Child Health
(ENRICH)
cohort study,
which began in
2013.
Participants
were recruited
from UNMaffiliated
prenatal care
clinics. Both
studies included
three visits: 1)
prenatal, during
one of the first
prenatal care
appointments;
2) early
postpartum,
during the
hospital stay
after labor and
delivery; and 3)
neurodevelopm
ental and SFP
assessment of
children at ~6
months of age.
The following
eligibility
criteria were
applied to all
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substance exposures is
further supported by the
result indicating that the
model containing maternal
contingent responding
accounted for 67% of the
variance, in contrast to 16%
for the model testing the
group effect.” (p. 7).
Conclusions: “In
conclusion, we found that
infants of mothers who used
contingent responsiveness
demonstrated more positive
affect during play episodes
of the SFP. Additionally,
infants displayed less
positivity when their
mothers used attention
seeking behaviors. Maternal
behavior did not vary
among the exposed and
unexposed subjects;
however, maternal behavior
had a much greater
influence on infant affect
compared to prenatal
exposures. Our findings are
relevant to infants exposed
to drugs and alcohol, as they
are often described as
dysregulated, easily
overstimulated, and
irritable. These results are
important because they
suggest that modifiable
postnatal factors play a role

Future studies should
examine the effects of the
timing of exposure and
different patterns of
substance use on infant stress
reactivity. Finally,
longitudinal studies should
also explore if the
improvement of infantmother interactions lead to
decreased behavioral
problems and/or improved
social functioning across
childhood in this vulnerable
population.” (p. 8)

sample, especially
beyond the
periconceptional period;
3) prenatal substance
exposure being a more
distant measure as
compared to maternal
behavior which is
measured in the same
dyadic context during
the SFP. Furthermore,
assessing infant affect
and maternal interaction
style within the same
paradigm limits the
generalizability of the
results; future studies
would benefit from
evaluating the effect of
parental style earlier in
life on more distant
infant behavioral
outcomes. Though there
were demographic
differences between the
groups, these were
controlled for in the
multivariable analyses.
Co-exposures with other
substances, especially
tobacco and marijuana,
were prevalent among
the three exposed
groups; however, since
Controls had no coexposure to these
substances by definition,
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participants: 1)
at least 18 years
old; 2)
singleton
pregnancy; 3)
currently
residing and
planning to stay
in the
Albuquerque
metropolitan
area to
complete all
study visits; 4)
ability to give
informed
consent in
English; and 5)
no fetal
diagnosis of a
major structural
anomaly.
Pregnant
women in both
cohort studies
were recruited
into one of four
mutually
exclusive study
groups, as
follows:
participants 1)
without
perinatal
substance
exposures
(Control); 2)
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in infant positivity, which
may help mediate effects of
prenatal substance
exposures” (p. 8).

we could not adjust for
them in multivariable
analyses. Finally while
we controlled for the key
socio-demographic
(marital status, maternal
education, family
income), medical
(depressive symptoms),
and infant (age at
assessment, sex) factors,
we recognize that there
are multiple other preand postnatal factors
which can affect infant
stress reactivity and
maternal behavior.”(pg
7, paragraph 6)
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with opioid use
disorder who
prenatally
received
medication
assisted therapy
(MAT; either
methadone or
buprenorphine)
and did not use
alcohol in
pregnancy; 3)
with alcohol
use during
pregnancy
(Alcohol); and
4) with MAT
and alcohol use
during
pregnancy
(Alcohol +
MAT). While
the focus of
both cohorts
was to ascertain
the effects of
prenatal alcohol
exposure on
infant
outcomes,
MAT and
Alcohol +
MAT groups
were included,
in addition to
unexposed
controls, to
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better match
pre- and postnatal
environmental
factors across
groups.
Participants
classified into
the control
group needed to
1) be a lifetime
abstainer of
illicit drugs and
tobacco
products
(reported use of
≤100 cigarettes
in lifetime); and
2) abstain from
alcohol use
since the last
menstrual
period (LMP)
and be no more
than a light
alcohol user (≤2
standard drinks/
week on
average) before
the LMP.
Participants
classified into
the alcoholexposed groups
(Alcohol,
Alcohol +
MAT) had to 1)
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self-report at
least moderate
levels of
drinking [37] in
the
periconceptiona
l period (≥3
drinks per week
or ≥2 binge
drinking
episodes
[‘binge’ defined
as ≥4 drinks per
occasion]
during the
month
surrounding the
LMP) using the
Timeline
Follow-Back
assessment
method; and 2)
continue
drinking during
pregnancy, as
confirmed by
self-report or
positive ethanol
biomarker. The
self-reported
cutoffs for risky
alcohol use
employed in
this study and
our conjunctive
use of ethanol
biomarkers in
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pregnancy are
rigorous and
well-supported
by the literature
[37–41]. The
final sample
size for this
analysis was 91
maternal-infant
pairs who had
completed the
three study
visits as of
January 2017.”
(p. 2)
Level of
Evidence:
Level 4
Lubbe, M., Walbeek, C.V.,
& Vellios, N.
(2017). The
prevalence of
fetal alcohol
syndrome and its
impact on a
child’s classroom
performance: A
case study of rural
south african
school. Internatio
nal Journal of
Environmental
Research and
Public Health. 14,
1-10. doi:

Statement: The
study aims to
reveal the
prevalence of
FAS is a rural
South African
school to observe
the effects of FAS
on students’
abilities,
interactions and
education

Setting: A farm
school in rural
South Africa near
Clanwilliam in the
South Western
Cape
Sampling
Method: Students
were chosen from
the poorest district,
or quantile in
Clanwilliam. The
students attending
this school are
more likely to be
neglected
physically and
emotionally at

Design: Seven
months were
spent observing
the language,
mathematics,
reading, and
behavior
abilities of the
166 students.
The data was
observed by the
researcher and
collected by the
teachers. The
researchers
used the
Behavioral
Observation of

Findings: 21 students were
diagnosed with FAS. In all
four categories of learning
children with FAS had
lower performance than
those without FAS.
Conclusion: The prevalence
of FAS is higher in farm
regions than in towns and
students with FAS perform
worse in educational
markers. The reason that
there is not a higher
difference in the
performance of students
with and without FAS could
be because the majority of
students come from homes

Research Implications:
Students who have FAS
should be placed in learning
environments that are noise
controlled, with less stimuli.
Limitations of findings

Limitations: There is a
small sample size. Only
FAS not all FASD were
diagnosed. There is a
possibility of bias or
error in the measurement
of the educational
outcomes.
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10.3390/ijerph140
80896.

Mark, K., Desai,
A., & Terplan, M.
(2015). Marijuana
use and
pregnancy:
Prevalence,
associated
characteristics,
and birth
outcomes.
Women’s Mental
Health

home.
Consumption of
alcohol in large
quantities is not
uncommon in this
community.
Alcohol is made at
home illegally and
sold. Workers
receive pay checks
on Fridays and sell
alcohol at the
farms where they
work

Purpose
Statement: “This
study examined
the prevalence,
behaviors, and
birth outcomes
associated with
marijuana use in
pregnancy” (pg 1)
Research
question: What
does the

Sample size: 398
patients
Setting: single
urban university
affiliated clinic
from July 1 2009June 30 2010
Sample methods:
intake data
retrieved from the
prenatal chart
which included a

Students in
School (BOSS).
TO collect data
on behaviors,
each student
underwent two
15-minute
BOSS sessions
over six
months. A
medical doctor
in the area
provided data
on the diagnosis
of FAS on each
student.
Information
was
documented on
the FAS
assessment
form
Level of
Evidence: V
Design: a chart
review of all
patients
presenting for
prenatal care;
retrospective
cohort
Level of
evidence: Level
III
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that are dysfunctional to
some significant degree

Findings: intake 116
(29.3%) screened positive
for marijuana either by selfreport or urine toxicology.
116, 27 were positive by
urine only, 35 by self-report
only, 54 by both urine by
both urine and self-report
Conclusion: prevalence of
marijuana that reported at
29.3% was higher than that
reported in the national
survey on drug use and

Research implications:
Despite the high prevalence
of marijuana use prenatal
care, most women stopped
using marijuana during
pregnancy. Only three
women had a positive
toxicology screen at the time
of delivery

Limitations to findings:
retrospective cohort that
relies partially on
provider documentation
of screening. May have
had selection bias, not
consistently screened
with urine toxicology.
Frequency of marijuana
use was not elicited nor
was detailed information
about a quit date
obtained.
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May, P.A.,
Chambers, C.D.,
Kalberg, W.O.,
Zellner, J.,
Feldman, H.,
Buckley, D., &
Hoyme, H.E.
(2018).
Prevalence of
fetal alcohol
spectrum
disorders in 4 US
communities.
American
Medical
Association.
.doi:10.1001/jama
.2017.21896

prevalence of
marijuana use
during
pregnancy?
Purpose
Statement: “To
estimate the
prevalence of
fetal alcohol
spectrum
disorders,
including fetal
alcohol syndrome,
partial fetal
alcohol syndrome,
and alcoholrelated
neurodevelopmen
tal disorder in 4
regions of the
United States
Research
question: How
prevalent are fetal
alcohol spectrum
disorders in the
United States?

complete social
work eval.

Setting: Four
Communities in
the Rocky
Mountain,
Midwestern, South
Eastern, and
Pacific
Southwestern
regions of the
United States
Sampling Method:
First-grade
children and their
parents or
guardians. A cross
sectional design
was used to assess
children for fetal
alcohol spectrum
disorders between
2010-2016.
Children were
systematically
assessed in the four
domains that
contribute to the
fetal alcohol
spectrum disorder:
dysmorphic
features, physical
growth,
neurobehavioral

Design: Activecase
ascertainment
with a crosssectional design
was used at 4
community
sites, a
convenience
sample that was
selected based
on the
investigators’
ability to
engage the
individual
communities
and on the
feasibility of
conducting the
study in that
community
Level of
Evidence:
Level V or VI
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health. Despite high
prevalence, most of the
women stopped using
marijuana during pregnancy
Findings: Prevalence of
fetal alcohol spectrum
disorders in the 4
communities was the main
outcome. Conservative
estimates for the prevalence
of the disorder and 95% CIs
were calculated using the
eligible first-grade
population as the
denominator. Weighted
prevalence and 95% CIs
were also estimated,
accounting for the sampling
schemes and using data
restricted to children who
received a full evaluation.
222 cases of fetal alcohol
spectrum disorders were
identified. The conservative
prevalence estimates for
fetal alcohol spectrum
disorders ranged from 11.3
(95% CI, 7.8-15.8) to 50.0
(95% CI, 39.9-61.7) per
1000 children. The
weighted prevalence
estimates for fetal alcohol
spectrum disorders ranged
from 31.1 (95% CI, 16.154.0) to 98.5 (95% CI, 57.5139.5) per 1000 children

Practice and Research
Implications: Findings may
represent more accurate US
prevalence estimates than
previous studies but may not
be generalizable to all
communities.

Limitation of Findings:
due to local policy
variations in the modes
of access allowed for
recruitment of children,
as well as variability in
willingness to consent,
no individual sample
evaluated the entire
eligible population.
Consent rates for
screening ranged from
36.9%-92.5% in
individual samples and
overall consent rates for
screening averaged only
59.9% of eligible
children. If non
consented children
differed from consented,
this could have biased
prevalence estimates in
either direction. Second:
numbers of cases of each
category of fetal alcohol
spectrum disorder in
each sample are small,
leading to wide CIs.
Third: neurobehavioral
testing at this age may
have missed some
children with deficits
that would no become
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development, and
prenatal alcohol
exposure

Conclusion: Estimated
prevalence of fetal alcohol
spectrum disorders among
first graders in 4 US
communities ranged from
1.1%-5.0% using a
conservative approach.
These findings may
represent more accurate US
prevalence estimates than
previous studies but may
not be generalizable to all
communities

Sampling Size:
6639 Children
from a population
of 13,146 first
graders (boys,
51.9%; mean age
6.7 years old and
white maternal
race, 79.3%

Metz, V. E.,
Brown, Q. L.,
Martins, S. S., &
Palamar, J. J.
(2018).
Characteristics of
drug use among
pregnant women
in the United
States: Opioid and
non-opioid illegal
drug use. Drug &

Purpose
Statement: “...the
aims of this study
were to: 1)
examine
associations
between
sociodemographic
characteristics,
mental health
characteristics,
and substance use

Setting: “The study
included data from
women aged 18–44
years from the
National Survey on
Drug Use and
Health (NSDUH),
years 2005–2014.
The NSDUH is an
annual, crosssectional,
nationally
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Design: “Data
on pregnant
women aged
18–44 reporting
past-year,
nonmedical
opioid use or
use of nonopioid illegal
drugs (other
than marijuana)
were analyzed

Findings: “Most women
were non-Hispanic White
(67.6%), had a high school
diploma or less education
(61.0%), a household
income < $20,000/year
(72.2%), and health
insurance coverage (84.3%).
No significant differences
between the three groups
were found regarding
sociodemographic

Practice and Research
Implications: “Despite
comparable
sociodemographic
characteristics among
pregnant drug-using women
in the US, opioid and nonopioid-using groups differed
regarding mental health
status and substance use
severity. This calls attention
to the need for access to

apparent until later ages,
which could have led to
underestimation of rates.
Fourth: this crosssectional study was
neither a longitudinal
nor a clinical sample.
Fifth criteria defining
neurobehavioral
impairment in this study
were selected to balance
sensitivity for deficits
that have functional
consequences with
specificity for the
characteristic
neurobehavioral
domains known to be
affected by prenatal
alcohol exposure. Also,
these four communities
in the study might not be
the greatest
representation for the
United States overall
Limitations of Findings:
“We could not determine
whether self-reported
past-year drug use
occurred only before
pregnancy or whether
these women were
aware, they were
pregnant when
(continuing) using drugs.
Furthermore, due to the
study’s cross-sectional
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Alcohol
Dependence, 183,
261–266.
https://doi.org/10.
1016/j.drugalcdep
.2017.11.010

profiles in order
to identify
correlates of
nonmedical
opioid use (i.e.,
nonmedical onlyopioid versus
opioid polydrug
use) and nonopioid illegal drug
use during
pregnancy, and 2)
estimate the
prevalence of
cigarettes,
alcohol, and
marijuana use by
pregnancy
trimester and
examine whether
use is correlated
with nonmedical
opioid and/or
other illegal drug
use.” (pg 2,
paragraph 2)
Research
Question: How
does
sociodemographic
, mental health,
and drug use
characteristics
correlate with
prevalence of
nonmedical
opioid and/or

representative
survey that
assesses substance
use and other
behaviors among a
probability sample
of noninstitutionalized
individuals living
in households
within the 50 US
states and the
District of
Columbia ages 12
years and older
(Substance Abuse
and Mental Health
Services
Administration"
(pg 2, paragraph 3)
Sample methods:
“Surveys were
administered via
computer-assisted
interviewing,
conducted by an
interviewer, and
audio computerassisted selfinterviewing.
Interviewers were
trained to not view
the screens during
survey
administration to
maintain the
privacy and

from the
National
Survey on Drug
Use and Health
(2005–2014).
Women (N =
818) were
categorized into
3 groups: 1) use
of opioids only
(n = 281), 2)
opioid polydrug
users (n = 241),
and 3) other
(non-opioid)
illegal drug
users (n = 296).
Characteristics
between the 3
groups of
women were
compared using
bivariable
analysis.” (p.1)
Level of
Evidence:
Level 6
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characteristics. Past-30-day
marijuana use was less
prevalent among opioidonly users (10.9%)
compared to opioidpolydrug users (43.6%) and
other pregnant illegal drug
users (27.6%) (P < 0.001)
and past-year drug/alcohol
treatment was less prevalent
among opioid-only users
(6.3%) compared to opioidpolydrug users (20.3%) and
other illegal drug users
(8.3%) (P = 0.002). Opioidonly users also reported
lower prevalence of pastyear depression (P < 0.001)
and anxiety (P = 0.039)”
(pg 1, paragraph 3)
Conclusions: “Pregnant
drug-using women were
often of low socioeconomic
status, with mental health
and substance use patterns
suggesting the need for
targeted mental
health/substance use
screening and interventions
before and during
pregnancy, particularly for
opioid-polydrug use” (p. 1)

mental health and drug use
screening for women of
childbearing age with low
socioeconomic status, as well
as for more targeted
prevention efforts aimed at
educating women of the risk
of prenatal substance use,
and the need for nonstigmatizing treatment
approaches for women who
misuse opioids and other
illegal drugs during all stages
of pregnancy” (p.5).

design, causality cannot
be inferred. In addition,
there might be trends
that could not be
accounted for, such as
that the proportion of
non-opioid illegal drug
using women decreased
over time. Also,
sensitivity analyses for
past-month use could not
be conducted due to too
few women in many
cells. This study only
included noninstitutionalized women,
so individuals not
included in the sample
(e.g., homeless) may be
underrepresented and
results may be less
generalizable to such
populations” (p. 5).
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another illegal
drug use?

confidentiality, and
to increase the
likelihood of
honest reporting
(Butler et al.,
2011). All
variables were selfreported. Sampling
weights were
provided by
NSDUH to account
for unit- and
individual-level
non-response and
adjusted to ensure
estimates were
consistent with
estimates provided
by the US Census
Bureau.
Aggregated data
from all cohorts of
pregnant women
aged 18–44 who
reported past-year,
nonmedical opioid
use and/or other
non-opioid illegal
drug use (other
than marijuana)
were examined (N
= 818). Analyses
were restricted to
this subset of
women, which is
consistent with
previous literature
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Nørgaard, M.,
Nielsson, M. S.,
& HeideJørgensen, U.
(2015). Birth and
Neonatal
Outcomes
following Opioid
Use in Pregnancy:
A Danish
Population-Based
Study. Substance
Abuse: Research
and Treatment,
9s2.

Purpose
Statement:
To examine
“adverse birth
outcomes in
women exposed
to methadone or
buprenorphine
during pregnancy
and the risk of
neonatal
abstinence
syndrome (NAS)
among neonates
exposed to
buprenorphine,
methadone,

examining prenatal
substance use
among adults
(Brown et al.,
2017; Ko et al.,
2015). The
weighted interview
response rates
ranged from 71.2–
76.0% annually”
(p.2).
Sample size: 818
pregnant women
aged 18–44 years
who reported pastyear nonmedical
opioid use and/or
another non-opioid
illegal drug use
Setting:
Denmark 1997–
2011
Sampling method:
“We included all
pregnant women
who during the
period 1997–2011
gave a live birth or
a stillbirth after the
20th week of
gestation. The
women were
identified through
the Danish Medical
Birth Registry,17
which contains
computerized

Design:
“The women
were identified
through the
Danish Medical
Birth
Registry,17
which contains
computerized
records of all
births in
Denmark since
January 1,
1973. Data
were recorded
by the
midwives or the
physicians
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Findings:
“we identified 557
pregnancies exposed to
buprenorphine, methadone,
and/or heroin (167 to
buprenorphine, 197 to
methadone, 28 to selfreported heroin, and 165 to
combinations)” (p. 1)
Conclusion:
“maternal use of
buprenorphine and
methadone during
pregnancy was associated
with increased prevalence
of adverse birth outcomes,
and this increase could only
be explained to a smaller

Practice and Research
Implications:
“We
had no method of identifying
women with an illicit use of
opioids who were not
undergoing treatment. It is
thus likely that we
have misclassified some of
the exposed women as
unexposed,
which would bias our relative
estimates toward the null” (p.
9).

Limitations:
“A major weakness of
our study is that the use
of prescription
data to identify the users
of buprenorphine did not
allow us to
distinguish between
prescriptions for
analgesic purposes only
and prescriptions to
opioid-dependent
women” (p. 10)
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and/or heroin in
utero” (p. 1).

records of all births
in Denmark since
January 1, 1973”
(p.1)
Sample size:
“950,172
pregnancies in a
total of 571,823
women” (p.1).

attending the
deliveries. The
registry
includes
information on
maternal age,
parity,
multiplicity of
gestation, birth
weight,
gestational age,
self-reported
maternal
smoking status,
and delivery.
We obtained
information on
exposure by
combining data
from the Danish
Register of
Medicinal
Product
Statistics, and
from the
Registry of
Drug Abusers
Undergoing
Treatment.19
We linked all
data using the
10-digit civil
registration
number (the
CPR number)
which is a
unique
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extent by increased
prevalence of smoking. The
risk of NAS was eight-fold
higher in methadoneexposed neonates than that
in buprenorphine-exposed
neonates, but this difference
may at least partly be
explained by differences in
underlying indications
(analgesic versus opioid
maintenance treatment)
between the two groups”
(p.1).
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Osterman, R.L.,
Carle, A.C.,
Ammerman, R.T.,
& Gates, D.
(2014). Singlesession
motivational
intervention to
decrease alcohol
use during
pregnancy.
Journal of
Substance Abuse
Treatment

Purpose
Statement: the
effectiveness of a
single session of
motivational
interviewing (MI)
to decrease
alcohol use during
pregnancy
Research
question: Is a
single session of
motivational
interviewing
intervention
effectively
decrease alcohol
use during
pregnancy?

Setting: recruited
pregnant women at
three prenatal
clinics located in a
midwestern
university medical
center. Women
attending an
obstetrical clinic
treating lowmoderate risk
pregnancies, a
high-risk perinatal
center, or a nurse
practitioner/midwif
ery practice
consented to
participate in the
study (N=184). To
determine study
eligibility,
consenting women
completed baseline
demographic
information and

identifier
assigned, since
1968, to all
Danish
residents by the
Central Office
of Civil
Registration
and used in all
Danish
healthcare
registries" (p.2)
Design:
randomized
clinical trial.
Level of
Evidence:
Level II
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Findings: A single-session
MI approach was not
effective in decreasing
alcohol use during
pregnancy.
Conclusion: “Theory-based
influencers of behavior
change should be
considered to provide
interventions with the
greatest potential to
decrease prenatal alcohol
use in pregnant women less
motivated and less ready for
change” (p. 15).

Practice and Research
Implications: “Future studies
can increase the number of
sessions of the intervention
to increase potency of the
intervention” (p. 15).

Limitation of Findings:
all women in the current
study were attending
prenatal care visits with
no prescriptions to the
standard care or
education provided
regarding the risks of
prenatal alcohol use.
Another is the inability
to interpret the
curvilinear relationships
in drinking behaviors
due to only three time
points of data collected
was a study limitation.
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instruments
measuring alcohol
use for the
previous 30 days
and previous year.
Pregnant women
who were 36
weeks or less
gestation, between
the ages of 18 and
44 years inclusive,
able to understand,
speak, and read
English, who
reported any
alcohol use in the
previous year, and
being available for
telephone followups at 30 days
postbaseline and
30 days postpartum
were eligible
Sampling Method:
Eligible pregnant
women who drank
any amount of
alcohol in the
previous year
(n=122) were
randomized to an
intervention or
comparison group
Sampling Size:
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Patrick, S. W.,
Dudley, J.,
Martin, P. R.,
Harrell, F. E.,
Warren, M. D.,
Hartmann, K. E.,
… Cooper, W. O.
(2015).
Prescription
Opioid Epidemic
and Infant
Outcomes.
Pediatrics,
135(5), 842–850.
https://doi.org/10.
1542/peds.20143299

Purpose
Statement: “to
identify neonatal
complications
associated with
antenatal opioid
pain reliever
exposure and to
establish
predictors of
neonatal
abstinence
syndrome
(NAS).” (p. 1)
Research
question:
Is the use of
opioid painkillers
during pregnancy
associated with
negative neonatal
outcomes like
neonatal
abstinence
syndrome?

122 pregnant
women
. Setting:
“prescription and
administrative data
linked to vital
statistics for
mothers and
infants enrolled in
the Tennessee
Medicaid program
between 2009 and
2011” (p. 1).
Sampling method:
“Maternal and
infant dyads were
included in the
study if: (1) the
mother was 15 to
44 years old at the
time of delivery;
(2) the mother had
been enrolled in
TennCare at least
30 days before
delivery; and (3)
the infants were
enrolled in
TennCare within
30 days after
delivery. Last
menstrual period
and date of
delivery were
obtained from vital
records.17
Pregnancies were

Design:
“retrospective,
longitudinal
cohort study
Level of
Evidence:
Level IIII
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Findings: “Of pregnant
women, 28% ﬁlled one or
more opioid prescription.
Women prescribed opioid
pain relievers were more
likely than those not
prescribed opioids to have
depression (5.3% vs 2.7%),
anxiety disorder (4.3% vs
1.6%) and to smoke tobacco
(41.8% vs 25.8%). Infants
with NAS and opioidexposed infants were more
likely than unexposed
infants to be born at a low
birth weight (21.2% vs
11.8% vs 9.9%). In a
multivariable model, higher
cumulative opioid exposure
for short-acting preparations
(P , .001), opioid type (P ,
.001), number of daily
cigarettes smoked (P , .001),
and selective serotonin
reuptake inhibitor use (odds
ratio: 2.08 [95% conﬁdence
interval: 1.67–2.60]) were
associated with greater risk
of developing NAS.” (p. 1)

Conclusion:” Prescription
opioid use in pregnancy is
common and strongly
associated with neonatal

Practice and Research
Implications: “Prescription
opioid use in pregnancy is
common and strongly
associated with neonatal
complications. Antenatal
cumulative prescription
opioid exposure, opioid type,
tobacco use, and selective
serotonin reuptake inhibitor
use increase the risk of
neonatal abstinence
syndrome” (p. 6).

Limitations: Due to the
use of hospital
administrative and vital
statistics data, errors of
omission, and
commission are possible,
leading to
misclassiﬁcation bias;
however, the medical
record review suggested
that potential
misclassiﬁcation of
outcomes was likely to
be small. There was no
direct observation of
women in our cohort
taking the prescribed
OPR. It is possible that
OPR medications were
not taken as prescribed,
resulting in a bias
toward the null
hypothesis. Inability to
capture other exposures
(eg, illicit drugs) that
may have inﬂuenced the
primary outcome (NAS).
Opioids obtained by
other legal sources not
paid for by TennCare
(ie, cash payments) were
not captured in the
sample, which could
bias the results toward
the null hypothesis.
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included if the
birth occurred
between January 1,
2009, and
December 31,
2011. Of a total
134450 births,
11202” (p. 2).
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complications. Antenatal
cumulative prescription
opioid exposure, opioid
type, tobacco use, and
selective serotonin reuptake
inhibitor use increases the
risk of NAS” (p. 1).

Conversion to morphine
milligram
equivalents may not
create perfect
comparisons of various
OPRs. It is possible that
opioid prescribing is a
surrogate for other
unmeasured risk factors
for NAS; residual
confounding cannot be
completely ruled out.

.

Rendall-Mkosi,
K., Morojele, N.,
London, L.,
Moodley, S.,
Singh, C., &
Girdler-Brown, B.
(2013). A
randomized
controlled trial of
motivational
interviewing to
prevent risk for an
alcohol-exposed
pregnancy in the
Western Cape,
South Africa.
Addiction,
108(4), 725-732.
doi:
10.1111/add.1208

Purpose
Statement:
“To test the
effectiveness of
motivational
interviewing (MI)
to reduce the risk
of an alcohol
exposed
pregnancy (AEP)
in a high-risk
population.” (p.1)

Sample size:
112029 pregnant
mothers
Setting: “Rural
population in the
Western Cape,
South Africa.”
(p.1)
Sampling methods:
“Participants were
recruited from six
primary care
clinics and from
farms within the
study area between
June and
November 2007.
Eligibility criteria
included: (i) age
18–44 years; (ii)
not pregnant; (iii)
engaged in risky
drinking (deﬁned
under Measures);
(iv) ineffective or
no contraceptive
use (deﬁned under

Design:
“Randomized
control trial.”
(p.1)
Level of
evidence:
Level II

Findings: “There was a
signiﬁcant difference in the
decline in the proportion of
women at risk for an AEP in
the MI group at 3 months
(50 versus 24.59%; P =
0.004), maintained at 12
months (50.82 versus
28.12%; P = 0.009)” (p.1)

Practice and Research
Implications: “There were
potential biases in this study.
There are limitations with
relying on self-reported data.
In addition, the failure to use
a timeline follow-back
method to assess the
women’s alcohol
consumption may have
reduced the reliability of selfreports. Interview fatigue
may have influenced them to
answer what they thought the
fieldworker would prefer to
hear” (p. 7)

Limitations: There was a
small sample size,
limited to a rural setting
in Africa.
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Measures); (v) had
not undergone
sterilization or
hysterectomy;(vi)
had vaginal sex in
the past 3 months;
and resided within
a 25-km radius of
the main town.”
(p.2)
Random sampling.
Sample size:
“A total of 165
women aged 18–44
years at risk of
AEP” (p.1)

Savory, J.,
Couves, J., &
Burns, E. (2014).
Alcohol
consumption
during pregnancy:
Cross-sectional
survey. Midwifery

Purpose
Statement: “ to
assess the
prevalence and
pattern of alcohol
consumption preconception and/or
during the ﬁrst
trimester using
the Alcohol Use
Disorders
Identiﬁcation Test
(AUDIT),
Alcohol Use
Disorders
Identiﬁcation Test
– Consumption
(AUDIT-C) and

Setting: two
antenatal clinics in
the south west of
England
Sampling methods:
Sample size: 500
pregnant women
attending their first
antenatal
appointment at
approximately 1011 weeks gestation

Design: Cross
sectional survey
. Level of
Evidence:
Level III

Findings: quarter of women
reported drinking alcohol
despite being aware they are
pregnant. Between two to
three in every 100 women
reported drinking six or
more units on a single
occasion at least monthly or
weekly in the past three
months,
Conclusion: these women
were willing to complete
brief alcohol screening
questionnaires. Minority of
the women reported
drinking preconception and
or during the first trimester
with a small percentage

Practice & Research
Implications:
Use of these questionnaires
would help midwives gather
info about alcohol are used to
help identify women
drinking at levels in excess
of recommended limits so
that appropriate advice and
support can be offered.

Limitations of Findings:
Alcohol intake was selfreported by women and
therefore they may be
underreporting due to
social stigma. They
found difficulties with
people’s perceptions of
what constitutes a drink.
Estimating quantity and
frequency of alcohol
consumed is difficult
due to lack of
understanding about
alcohol units and is
dependent on glass size
and drink strength.
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Warshak, C.R.,
Regan, J., Moore,
B., Magner, K.,
Kritzer, S., & Van
Hook, J. (2015).
Association
between
marijuana use and
adverse
obstetrical
neonatal
outcomes.
Journal of
Perinatology

T-ACE
(Tolerance,
Annoyance, Cut
Down and EyeOpener) alcohol
screening
questionnaires,
and determine the
sociodemographic
predictors of
drinking in this
time period” (pg
1)
Research
Questions: What
is the prevalence
of alcohol during
pregnancy?
Purpose
Statement: “To
evaluate
associations
between
marijuana
exposure and
adverse outcomes
excluding women
with
polysubstance
abuse and
stratifying for
concurrent
maternal tobacco
use” (p. 1)
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drinking at levels
potentially harmful to the
fetus.

Setting: The
University of
Cincinnati Medical
Center between
January 2008 and
January 2011
Sampling methods:
Marijuana users
were designated as
such if they
reported use during
the course of their
prenatal care or at
the time of
delivery or if at
any point during
the pregnancy they

Design:
retrospective
cohort study
Level of
Evidence:
Level IV

Finding: nonusers: n=6107
(94.4%) users: n=361
(5.6%). marijuana users
tended to be slightly
younger than nonusers, 24
years versus 25.3 years.
Marijuana users had
clinically similar gestational
ages at presentation for
prenatal care. Did not find
increased risks of several
adverse obstetric outcomes
in marijuana users versus
non users including preterm
delivery, pre-eclampsia, or
unplanned cesarean
delivery. Marijuana users
had a lower rate of

Practice & Research
Implications:
They had a large number of
women included in their
analysis and their ability to
control the confounding
medical and social factors
(race, obesity and lack of
adequate prenatal care) Rates
of marijuana use are
comparable to those
generally reported and
therefore they likely had
reasonable ascertainment of
use from the medical record.

Limitations of Findings:
The authors declare no
conflict of interest. Their
study was not designed
to determine doserelated effects and
patients were
characterized simply as
users or nonusers
although it is
physiologically plausible
that there may be
differences in outcomes
based upon increased
use. There center is a
high risk academic
center with a large
referral base and as such

INTERVENTIONS FOR DRUG USE IN PREGNANCY
Research
Question: Is there
an association
between
marijuana use and
adverse
obstetrical and
neonatal
outcome?

had a positive
toxicology screen
for
tetrahydrocannabin
ol universal drug
screening was not
used during the
study period but
was performed in
pregnancies
deemed to be high
risk for substance
abuse, secondary
to known history
of substance abuse,
poor prenatal care
or social/medical
risk factors for
drug abuse.

Sample size: 6468
pregnant women
(6107 nonusers,
361 users of
marijuana)
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gestational diabetes and a
lower rate of induction.
Conclusion: Study did not
find significant increases in
these outcomes in women
who also smoked tobacco.

our rates of exposures
and outcomes may vary
from other regions. They
only reported on
outcomes to neonatal
discharge. There is
consistent data that
marijuana exposure
during pregnancy and
breastfeeding contributes
of long term cognitive
gross motor and
neurodevelopmental
impairments in the
offspring of these
women

